BEHIND RIABNI® ANSWERING THE GROWING NEED FOR BIOSIMILARS

Amgen is a leader in biologics with a growing portfolio in biosimilars.

  • HERITAGE

    AMGEN BRINGS 40+ YEARS OF HERITAGE AND EXPERTISE IN DEVELOPMENT AND MANUFACTURING OF BIOLOGICS1

    40 years of experience in biologics 40 years of experience in biologics
    40 years of experience in biologics 40 years of experience in biologics

    AT AMGEN, WE’RE COMMITTED TO DELIVERING QUALITY PRODUCTS TO EVERY PATIENT, EVERY TIME.

    See Amgen Expertise
  • Expertise

    AMGEN'S EXPERIENCE IN BIOLOGICS DEVELOPMENT HAS PAVED THE WAY FOR OUR LEADERSHIP IN BIOSIMILARS

    • *Available biosimilars across all global markets as of February 2025.
    • †Based on data available for Mvasi, Amgevita, Kanjinti, Avsola, and Riabni as of June 2022.
    • ‡As of [June 30, 2025]. Number of non-oncology patients calculated from duration of therapy and adherence data from IQVIA Analytics Link and IQVIA Patient Link, respectively. Number of oncology patients determined using claims data (US) and physician surveys (ex-US). Patient count estimates may not accurately reflect the actual number of patients treated with Amgen biosimilars if adherence or length of treatment in real world differs from the assumptions used.
    See Amgen's Commitment to Biosimilars
  • Commitment

    AMGEN IS A LONG-STANDING BIOTECHNOLOGY LEADER COMMITTED TO DEVELOPING THE BIOSIMILAR MARKETPLACE

    OUR BIOSIMILAR PIPELINE IS TARGETED TO ADDRESS THE GREATEST TREATMENT NEEDS WITHOUT COMPROMISING HIGH-LEVEL CUSTOMER SERVICE

    27 oncology biologics and 6 biosimilars currently in development 27 oncology biologics and 6 biosimilars currently in development
    Learn about Amgen Support
  • Support

    WE ARE COMMITTED TO PROVIDING SOLUTION-ORIENTED RESOURCES THAT CAN HELP PROVIDE POSITIVE BIOSIMILAR EXPERIENCES

logo-amgen-biosim
Get the story behind Amgen's commitment to biosimilars
See the totality of evidence behind RIABNI®
×
Amgen stands with our local Los Angeles community. Click here to learn what we are doing to support and contact us if the fires have impacted your access to Amgen medication.